Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 157 to 167 of 167 entries
Sorted by: Best Match Show Resources per page
Development of Quinoa Value Chain to Improve Food and Nutritional Security in Rural Communities in Rehamna, Morocco: Lessons Learned and Perspectives.

Plants (Basel, Switzerland)

Hirich A, Rafik S, Rahmani M, Fetouab A, Azaykou F, Filali K, Ahmadzai H, Jnaoui Y, Soulaimani A, Moussafir M, El Gharous M, Karboune S, Sbai A, Choukr-Allah R.
PMID: 33562429
Plants (Basel). 2021 Feb 05;10(2). doi: 10.3390/plants10020301.

Agricultural production in the Rehamna region, Morocco is limited with various challenges including drought and salinity. Introduction of climate resilient and rustic crops such as quinoa was an optimal solution to increase farmer's income and improve food security. This...

Cite
Hirich A, Rafik S, Rahmani M, et al. Development of Quinoa Value Chain to Improve Food and Nutritional Security in Rural Communities in Rehamna, Morocco: Lessons Learned and Perspectives. Plants (Basel). 2021;10(2)doi: 10.3390/plants10020301.
Hirich, A., Rafik, S., Rahmani, M., Fetouab, A., Azaykou, F., Filali, K., Ahmadzai, H., Jnaoui, Y., Soulaimani, A., Moussafir, M., El Gharous, M., Karboune, S., Sbai, A., & Choukr-Allah, R. (2021). Development of Quinoa Value Chain to Improve Food and Nutritional Security in Rural Communities in Rehamna, Morocco: Lessons Learned and Perspectives. Plants (Basel, Switzerland), 10(2), . https://doi.org/10.3390/plants10020301
Hirich, Abdelaziz, et al. "Development of Quinoa Value Chain to Improve Food and Nutritional Security in Rural Communities in Rehamna, Morocco: Lessons Learned and Perspectives." Plants (Basel, Switzerland) vol. 10,2 (2021). doi: https://doi.org/10.3390/plants10020301
Hirich A, Rafik S, Rahmani M, Fetouab A, Azaykou F, Filali K, Ahmadzai H, Jnaoui Y, Soulaimani A, Moussafir M, El Gharous M, Karboune S, Sbai A, Choukr-Allah R. Development of Quinoa Value Chain to Improve Food and Nutritional Security in Rural Communities in Rehamna, Morocco: Lessons Learned and Perspectives. Plants (Basel). 2021 Feb 05;10(2). doi: 10.3390/plants10020301. PMID: 33562429; PMCID: PMC7915470.
Copy Download .nbib Format: NLM
Data mining approaches to understanding the formation of secondary organic aerosol.

Atmospheric environment (Oxford, England : 1994)

Olson DA, Offenberg JH, Lewandowski M, Kleindienst TE, Docherty KS, Jaoui M, Krug J, Riedel TP.
PMID: 33897265
Atmos Environ (1994). 2021 May 01;252. doi: 10.1016/j.atmosenv.2021.118345.

This research used data mining approaches to better understand factors affecting the formation of secondary organic aerosol (SOA). Although numerous laboratory and computational studies have been completed on SOA formation, it is still challenging to determine factors that most...

Cite
Olson DA, Offenberg JH, Lewandowski M, et al. Data mining approaches to understanding the formation of secondary organic aerosol. Atmos Environ (1994). 2021;252doi: 10.1016/j.atmosenv.2021.118345.
Olson, D. A., Offenberg, J. H., Lewandowski, M., Kleindienst, T. E., Docherty, K. S., Jaoui, M., Krug, J., & Riedel, T. P. (2021). Data mining approaches to understanding the formation of secondary organic aerosol. Atmospheric environment (Oxford, England : 1994), 252. https://doi.org/10.1016/j.atmosenv.2021.118345
Olson, David A, et al. "Data mining approaches to understanding the formation of secondary organic aerosol." Atmospheric environment (Oxford, England : 1994) vol. 252 (2021). doi: https://doi.org/10.1016/j.atmosenv.2021.118345
Olson DA, Offenberg JH, Lewandowski M, Kleindienst TE, Docherty KS, Jaoui M, Krug J, Riedel TP. Data mining approaches to understanding the formation of secondary organic aerosol. Atmos Environ (1994). 2021 May 01;252. doi: 10.1016/j.atmosenv.2021.118345. PMID: 33897265; PMCID: PMC8059534.
Copy Download .nbib Format: NLM
Evaluation of aesthetic outcomes of breast-conserving surgery by the surgeon, nurse, and patients: An analysis.

Asian journal of surgery

Yamamoto S, Chishima T, Sugae S, Yamagishi S, Yamada A, Narui K, Misumi T, Ishikawa T, Endo I.
PMID: 33879361
Asian J Surg. 2021 Apr 17; doi: 10.1016/j.asjsur.2021.03.034. Epub 2021 Apr 17.

BACKGROUND: Evaluation of the cosmetic outcome after breast-conserving surgery (BCS) differs depending on the evaluator. We performed a clinical trial to examine the differences between assessments of cosmetic outcomes performed by a surgeon, patients, and a nurse as a...

Cite
Yamamoto S, Chishima T, Sugae S, et al. Evaluation of aesthetic outcomes of breast-conserving surgery by the surgeon, nurse, and patients: An analysis. Asian J Surg. 2021;doi: 10.1016/j.asjsur.2021.03.034.
Yamamoto, S., Chishima, T., Sugae, S., Yamagishi, S., Yamada, A., Narui, K., Misumi, T., Ishikawa, T., & Endo, I. (2021). Evaluation of aesthetic outcomes of breast-conserving surgery by the surgeon, nurse, and patients: An analysis. Asian journal of surgery, . https://doi.org/10.1016/j.asjsur.2021.03.034
Yamamoto, Shinya, et al. "Evaluation of aesthetic outcomes of breast-conserving surgery by the surgeon, nurse, and patients: An analysis." Asian journal of surgery vol. (2021). doi: https://doi.org/10.1016/j.asjsur.2021.03.034
Yamamoto S, Chishima T, Sugae S, Yamagishi S, Yamada A, Narui K, Misumi T, Ishikawa T, Endo I. Evaluation of aesthetic outcomes of breast-conserving surgery by the surgeon, nurse, and patients: An analysis. Asian J Surg. 2021 Apr 17; doi: 10.1016/j.asjsur.2021.03.034. Epub 2021 Apr 17. PMID: 33879361.
Copy Download .nbib Format: NLM
SCOPe: improvements to the structural classification of proteins - extended database to facilitate variant interpretation and machine learning.

Nucleic acids research

Chandonia JM, Guan L, Lin S, Yu C, Fox NK, Brenner SE.
PMID: 34850923
Nucleic Acids Res. 2022 Jan 07;50:D553-D559. doi: 10.1093/nar/gkab1054.

The Structural Classification of Proteins-extended (SCOPe, https://scop.berkeley.edu) knowledgebase aims to provide an accurate, detailed, and comprehensive description of the structural and evolutionary relationships amongst the majority of proteins of known structure, along with resources for analyzing the protein structures...

Cite
Chandonia JM, Guan L, Lin S, et al. SCOPe: improvements to the structural classification of proteins - extended database to facilitate variant interpretation and machine learning. Nucleic Acids Res. 2022;50:D553-D559doi: 10.1093/nar/gkab1054.
Chandonia, J. M., Guan, L., Lin, S., Yu, C., Fox, N. K., & Brenner, S. E. (2022). SCOPe: improvements to the structural classification of proteins - extended database to facilitate variant interpretation and machine learning. Nucleic acids research, 50D553-D559. https://doi.org/10.1093/nar/gkab1054
Chandonia, John-Marc, et al. "SCOPe: improvements to the structural classification of proteins - extended database to facilitate variant interpretation and machine learning." Nucleic acids research vol. 50 (2022): D553-D559. doi: https://doi.org/10.1093/nar/gkab1054
Chandonia JM, Guan L, Lin S, Yu C, Fox NK, Brenner SE. SCOPe: improvements to the structural classification of proteins - extended database to facilitate variant interpretation and machine learning. Nucleic Acids Res. 2022 Jan 07;50:D553-D559. doi: 10.1093/nar/gkab1054. PMID: 34850923.
Copy Download .nbib Format: NLM
A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with .

Cancer management and research

Igawa S, Kasajima M, Ono T, Ozawa T, Kakegawa M, Kusuhara S, Sato T, Nakahara Y, Fukui T, Yokoba M, Kubota M, Mitsufuji H, Sasaki J, Naoki K.
PMID: 34849025
Cancer Manag Res. 2021 Nov 20;13:8695-8705. doi: 10.2147/CMAR.S339891. eCollection 2021.

BACKGROUND: The clinical outcomes of elderly patients with PATIENTS AND METHODS: We assessed the clinical effects of osimertinib as a first-line treatment for elderly NSCLC patients (≥75 years of age) with an exon 19 deletion or exon 21 L858R...

Cite
Igawa S, Kasajima M, Ono T, et al. A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with . Cancer Manag Res. 2021;13:8695-8705doi: 10.2147/CMAR.S339891.
Igawa, S., Kasajima, M., Ono, T., Ozawa, T., Kakegawa, M., Kusuhara, S., Sato, T., Nakahara, Y., Fukui, T., Yokoba, M., Kubota, M., Mitsufuji, H., Sasaki, J., & Naoki, K. (2021). A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with . Cancer management and research, 138695-8705. https://doi.org/10.2147/CMAR.S339891
Igawa, Satoshi, et al. "A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with ." Cancer management and research vol. 13 (2021): 8695-8705. doi: https://doi.org/10.2147/CMAR.S339891
Igawa S, Kasajima M, Ono T, Ozawa T, Kakegawa M, Kusuhara S, Sato T, Nakahara Y, Fukui T, Yokoba M, Kubota M, Mitsufuji H, Sasaki J, Naoki K. A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with . Cancer Manag Res. 2021 Nov 20;13:8695-8705. doi: 10.2147/CMAR.S339891. eCollection 2021. PMID: 34849025; PMCID: PMC8612658.
Copy Download .nbib Format: NLM
Definitive radiotherapy for squamous cell carcinoma of the oral cavity: a single-institution experience.

Radiology and oncology

Lang K, Baur M, Held T, Shafie RE, Moratin J, Freudlsperger C, Zaoui K, Bougatf N, Hoffmann J, Plinkert PK, Debus J, Adeberg S.
PMID: 34821134
Radiol Oncol. 2021 Nov 19;55(4):467-473. doi: 10.2478/raon-2021-0041.

BACKGROUND: Surgery is standard of care for oral cavity cancer (OCC). We provide a single-institution experience using definitive radiotherapy (RT) with or without concurrent systemic therapy for primary unresectable OCC.PATIENTS AND METHODS: We retrospectively examined 49 patients with non-metastatic...

Cite
Lang K, Baur M, Held T, et al. Definitive radiotherapy for squamous cell carcinoma of the oral cavity: a single-institution experience. Radiol Oncol. 2021;55(4):467-473doi: 10.2478/raon-2021-0041.
Lang, K., Baur, M., Held, T., Shafie, R. E., Moratin, J., Freudlsperger, C., Zaoui, K., Bougatf, N., Hoffmann, J., Plinkert, P. K., Debus, J., & Adeberg, S. (2021). Definitive radiotherapy for squamous cell carcinoma of the oral cavity: a single-institution experience. Radiology and oncology, 55(4), 467-473. https://doi.org/10.2478/raon-2021-0041
Lang, Kristin, et al. "Definitive radiotherapy for squamous cell carcinoma of the oral cavity: a single-institution experience." Radiology and oncology vol. 55,4 (2021): 467-473. doi: https://doi.org/10.2478/raon-2021-0041
Lang K, Baur M, Held T, Shafie RE, Moratin J, Freudlsperger C, Zaoui K, Bougatf N, Hoffmann J, Plinkert PK, Debus J, Adeberg S. Definitive radiotherapy for squamous cell carcinoma of the oral cavity: a single-institution experience. Radiol Oncol. 2021 Nov 19;55(4):467-473. doi: 10.2478/raon-2021-0041. PMID: 34821134.
Copy Download .nbib Format: NLM
Evaluation of the Apnea-Hypopnea Index Determined by Adaptive Servo-Ventilation Devices in Patients With Heart Failure and Sleep-Disordered Breathing.

Frontiers in cardiovascular medicine

Imanari S, Tomita Y, Kasagi S, Kawana F, Kimura Y, Ishiwata S, Narui K, Kasai T.
PMID: 34250041
Front Cardiovasc Med. 2021 Jun 25;8:680053. doi: 10.3389/fcvm.2021.680053. eCollection 2021.

No abstract available.

Cite
Imanari S, Tomita Y, Kasagi S, et al. Evaluation of the Apnea-Hypopnea Index Determined by Adaptive Servo-Ventilation Devices in Patients With Heart Failure and Sleep-Disordered Breathing. Front Cardiovasc Med. 2021;8:680053doi: 10.3389/fcvm.2021.680053.
Imanari, S., Tomita, Y., Kasagi, S., Kawana, F., Kimura, Y., Ishiwata, S., Narui, K., & Kasai, T. (2021). Evaluation of the Apnea-Hypopnea Index Determined by Adaptive Servo-Ventilation Devices in Patients With Heart Failure and Sleep-Disordered Breathing. Frontiers in cardiovascular medicine, 8680053. https://doi.org/10.3389/fcvm.2021.680053
Imanari, Satomi, et al. "Evaluation of the Apnea-Hypopnea Index Determined by Adaptive Servo-Ventilation Devices in Patients With Heart Failure and Sleep-Disordered Breathing." Frontiers in cardiovascular medicine vol. 8 (2021): 680053. doi: https://doi.org/10.3389/fcvm.2021.680053
Imanari S, Tomita Y, Kasagi S, Kawana F, Kimura Y, Ishiwata S, Narui K, Kasai T. Evaluation of the Apnea-Hypopnea Index Determined by Adaptive Servo-Ventilation Devices in Patients With Heart Failure and Sleep-Disordered Breathing. Front Cardiovasc Med. 2021 Jun 25;8:680053. doi: 10.3389/fcvm.2021.680053. eCollection 2021. PMID: 34250041; PMCID: PMC8267007.
Copy Download .nbib Format: NLM
Prognostic significance of galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapy.

Thoracic cancer

Kusuhara S, Igawa S, Ichinoe M, Nagashio R, Kuchitsu Y, Hiyoshi Y, Shiomi K, Murakumo Y, Saegusa M, Satoh Y, Sato Y, Naoki K.
PMID: 33793071
Thorac Cancer. 2021 May;12(10):1570-1578. doi: 10.1111/1759-7714.13945. Epub 2021 Apr 01.

BACKGROUND: Galectin-3 (GAL3), a protein encoded by the LGALS3 gene, plays diverse roles in cancer initiation, progression, and drug resistance. Accordingly, high GAL3 expression in tumor cells is associated with poor prognosis in non-small cell lung cancer (NSCLC). However,...

Cite
Kusuhara S, Igawa S, Ichinoe M, et al. Prognostic significance of galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapy. Thorac Cancer. 2021;12(10):1570-1578doi: 10.1111/1759-7714.13945.
Kusuhara, S., Igawa, S., Ichinoe, M., Nagashio, R., Kuchitsu, Y., Hiyoshi, Y., Shiomi, K., Murakumo, Y., Saegusa, M., Satoh, Y., Sato, Y., & Naoki, K. (2021). Prognostic significance of galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapy. Thoracic cancer, 12(10), 1570-1578. https://doi.org/10.1111/1759-7714.13945
Kusuhara, Seiichiro, et al. "Prognostic significance of galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapy." Thoracic cancer vol. 12,10 (2021): 1570-1578. doi: https://doi.org/10.1111/1759-7714.13945
Kusuhara S, Igawa S, Ichinoe M, Nagashio R, Kuchitsu Y, Hiyoshi Y, Shiomi K, Murakumo Y, Saegusa M, Satoh Y, Sato Y, Naoki K. Prognostic significance of galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapy. Thorac Cancer. 2021 May;12(10):1570-1578. doi: 10.1111/1759-7714.13945. Epub 2021 Apr 01. PMID: 33793071; PMCID: PMC8107024.
Copy Download .nbib Format: NLM
EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-Negative Head and Neck Cancers.

Frontiers in oncology

Mock A, Plath M, Moratin J, Tapken MJ, Jäger D, Krauss J, Fröhling S, Hess J, Zaoui K.
PMID: 34178665
Front Oncol. 2021 Jun 11;11:678966. doi: 10.3389/fonc.2021.678966. eCollection 2021.

While genetic alterations in Epidermal growth factor receptor (EGFR) and PI3K are common in head and neck squamous cell carcinomas (HNSCC), their impact on oncogenic signaling and cancer drug sensitivities remains elusive. To determine their consequences on the transcriptional...

Cite
Mock A, Plath M, Moratin J, et al. EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-Negative Head and Neck Cancers. Front Oncol. 2021;11:678966doi: 10.3389/fonc.2021.678966.
Mock, A., Plath, M., Moratin, J., Tapken, M. J., Jäger, D., Krauss, J., Fröhling, S., Hess, J., & Zaoui, K. (2021). EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-Negative Head and Neck Cancers. Frontiers in oncology, 11678966. https://doi.org/10.3389/fonc.2021.678966
Mock, Andreas, et al. "EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-Negative Head and Neck Cancers." Frontiers in oncology vol. 11 (2021): 678966. doi: https://doi.org/10.3389/fonc.2021.678966
Mock A, Plath M, Moratin J, Tapken MJ, Jäger D, Krauss J, Fröhling S, Hess J, Zaoui K. EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-Negative Head and Neck Cancers. Front Oncol. 2021 Jun 11;11:678966. doi: 10.3389/fonc.2021.678966. eCollection 2021. PMID: 34178665; PMCID: PMC8226088.
Copy Download .nbib Format: NLM
3D-printed individualized tooth-borne tissue retraction devices compared to conventional dental splints for head and neck cancer radiotherapy: a randomized controlled trial.

Radiation oncology (London, England)

Held T, Herpel C, Schwindling FS, Christ L, Lang K, Regnery S, Eichkorn T, Hommertgen A, Jaekel C, Krisam J, Moratin J, Mrosek J, Metzger K, Zaoui K, Moutsis T, Harrabi S, Herfarth K, Freudlsperger C, Rammelsberg P, Debus J, Adeberg S.
PMID: 33865401
Radiat Oncol. 2021 Apr 17;16(1):75. doi: 10.1186/s13014-021-01803-8.

BACKGROUND: Despite modern treatment techniques, radiotherapy (RT) in patients with head and neck cancer (HNC) may be associated with high rates of acute and late treatment-related toxicity. The most effective approach to reduce sequelae after RT is to avoid...

Cite
Held T, Herpel C, Schwindling FS, et al. 3D-printed individualized tooth-borne tissue retraction devices compared to conventional dental splints for head and neck cancer radiotherapy: a randomized controlled trial. Radiat Oncol. 2021;16(1):75doi: 10.1186/s13014-021-01803-8.
Held, T., Herpel, C., Schwindling, F. S., Christ, L., Lang, K., Regnery, S., Eichkorn, T., Hommertgen, A., Jaekel, C., Krisam, J., Moratin, J., Mrosek, J., Metzger, K., Zaoui, K., Moutsis, T., Harrabi, S., Herfarth, K., Freudlsperger, C., Rammelsberg, P., Debus, J., & Adeberg, S. (2021). 3D-printed individualized tooth-borne tissue retraction devices compared to conventional dental splints for head and neck cancer radiotherapy: a randomized controlled trial. Radiation oncology (London, England), 16(1), 75. https://doi.org/10.1186/s13014-021-01803-8
Held, Thomas, et al. "3D-printed individualized tooth-borne tissue retraction devices compared to conventional dental splints for head and neck cancer radiotherapy: a randomized controlled trial." Radiation oncology (London, England) vol. 16,1 (2021): 75. doi: https://doi.org/10.1186/s13014-021-01803-8
Held T, Herpel C, Schwindling FS, Christ L, Lang K, Regnery S, Eichkorn T, Hommertgen A, Jaekel C, Krisam J, Moratin J, Mrosek J, Metzger K, Zaoui K, Moutsis T, Harrabi S, Herfarth K, Freudlsperger C, Rammelsberg P, Debus J, Adeberg S. 3D-printed individualized tooth-borne tissue retraction devices compared to conventional dental splints for head and neck cancer radiotherapy: a randomized controlled trial. Radiat Oncol. 2021 Apr 17;16(1):75. doi: 10.1186/s13014-021-01803-8. PMID: 33865401; PMCID: PMC8052727.
Copy Download .nbib Format: NLM
NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer.

Oncogene

Boudhraa Z, Zaoui K, Fleury H, Cahuzac M, Gilbert S, Tchakarska G, Kendall-Dupont J, Carmona E, Provencher D, Mes-Masson AM.
PMID: 34743206
Oncogene. 2022 Jan;41(3):309-320. doi: 10.1038/s41388-021-02082-z. Epub 2021 Nov 06.

While aneuploidy is a main enabling characteristic of cancers, it also creates specific vulnerabilities. Here we demonstrate that Ran inhibition targets epithelial ovarian cancer (EOC) survival through its characteristic aneuploidy. We show that induction of aneuploidy in rare diploid...

Cite
Boudhraa Z, Zaoui K, Fleury H, et al. NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer. Oncogene. 2021;41(3):309-320doi: 10.1038/s41388-021-02082-z.
Boudhraa, Z., Zaoui, K., Fleury, H., Cahuzac, M., Gilbert, S., Tchakarska, G., Kendall-Dupont, J., Carmona, E., Provencher, D., & Mes-Masson, A. M. (2022). NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer. Oncogene, 41(3), 309-320. https://doi.org/10.1038/s41388-021-02082-z
Boudhraa, Zied, et al. "NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer." Oncogene vol. 41,3 (2022): 309-320. doi: https://doi.org/10.1038/s41388-021-02082-z
Boudhraa Z, Zaoui K, Fleury H, Cahuzac M, Gilbert S, Tchakarska G, Kendall-Dupont J, Carmona E, Provencher D, Mes-Masson AM. NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer. Oncogene. 2022 Jan;41(3):309-320. doi: 10.1038/s41388-021-02082-z. Epub 2021 Nov 06. PMID: 34743206.
Copy Download .nbib Format: NLM
Showing 157 to 167 of 167 entries